IBB
iShares Biotechnology ETF
1Y Return
N/A
Expense Ratio
0.44%
Dividend Yield
N/A
AUM
N/A
Basic Info
IssuerBlackRock
CategoryHealthcare
Inception Date2001-02-05
iShares Biotechnology ETF provides healthcare, biotechnology, or medical-device equity exposure.
Returns & Risk
1Y ReturnN/A
3Y (Ann.)N/A
5Y (Ann.)N/A
VolatilityN/A
Sharpe RatioN/A
Max DrawdownN/A
Top 10 Holdings
Eli Lilly
8.0%
UnitedHealth
7.0%
Johnson & Johnson
6.0%
AbbVie
5.0%
Thermo Fisher
4.0%
Sector Allocation
Healthcare
85.0%
Technology
6.0%
Consumer
4.0%
Financials
3.0%
Others
2.0%
Historical Annual Returns
Annual returns over the past 6 years
NaN%NaN%
NaN%2020
NaN%2021
NaN%2022
NaN%2023
NaN%2024
NaN%2025
AI Analysis
IBB each have distinct characteristics. IBB led with a 1-year return of N/A, while IBB returned N/A. IBB has the lowest expense ratio at 0.44%. See detailed comparison below.
Investor Profile
Conservative: Focus on low-volatility, high-dividend ETFs. Keep total allocation under 60% of portfolio Aggressive: Core position in IBB (50%) with diversified allocation for the rest Moderate: 30-40% per ETF with periodic rebalancing
Risk Warning
Past performance does not guarantee future results. Make decisions based on your financial situation and risk tolerance